NOZINAN 25 mg/ml, solution for injection in an ampoule (i.m.) 5 ampoules of 1 ml
Active ingredients: Levomepromazine hydrochloride, Levomepromazine
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection5 ampoules of 1 mlintramusculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NOZINAN 25 mg/ml, solution injectable en ampoule (I.M.)
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire
- Presentation description
- 5 ampoule(s) en verre de 1 ml
- Marketing authorisation holder
- NEURAXPHARM FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Dec 1986
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64026417CIP73272578CIP133400932725786Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LÉVOMÉPROMAZINEsolution | 25,00 mg · 1 ml de solution | FT |
| CHLORHYDRATE DE LÉVOMÉPROMAZINEsolution | 27,78 mg · 1 ml de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.